ImmunityBio Inc.

NASDAQ: IBRX · Real-Time Price · USD
2.54
-0.17 (-6.27%)
At close: Aug 15, 2025, 3:59 PM
2.56
0.59%
After-hours: Aug 15, 2025, 07:58 PM EDT

ImmunityBio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-413.64M -583.2M -417.32M -349.85M
Depreciation & Amortization
17.55M 18.51M 18.26M 14.24M
Stock-Based Compensation
34.43M 49.16M 40.18M 57.18M
Other Working Capital
-5.62M 10.45M -16M -15.39M
Other Non-Cash Items
-10.15M 144.79M 29.38M 23.13M
Deferred Income Tax
n/a n/a -4K -8K
Change in Working Capital
-19.42M 3.98M -8M -19.11M
Operating Cash Flow
-391.24M -366.76M -337.51M -274.42M
Capital Expenditures
-6.89M -30.58M -99.39M -33.56M
Cash Acquisitions
-1M n/a -1M 20.5M
Purchase of Investments
-140.22M -10.36M -34.31M -141.75M
Sales Maturities Of Investments
136.61M 10.47M 162M 69.93M
Other Investing Acitivies
-747K n/a 105.46M -51.32M
Investing Cash Flow
-12.25M -30.47M 27.3M -84.89M
Debt Repayment
-64K 258.62M 174.07M 338.5M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
170.34M 189.62M -881K 2.41M
Financial Cash Flow
281.63M 558.34M 233.61M 505.44M
Net Cash Flow
-121.88M 160.82M -76.31M 146.19M
Free Cash Flow
-398.12M -397.34M -436.9M -307.98M